Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-100.00%
↓ 16852% below average
Average (23q)
0.60%
Historical baseline
Range
High:98.16%
Low:-100.00%
Volatility
33195.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | -13.73% |
| Q1 2025 | 13.85% |
| Q4 2024 | 13.09% |
| Q3 2024 | 60.79% |
| Q2 2024 | -67.40% |
| Q1 2024 | -5.36% |
| Q4 2023 | -24.06% |
| Q3 2023 | 98.16% |
| Q2 2023 | -49.11% |
| Q1 2023 | 88.09% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |